Because the functional importance of Lrig1 in various metabolic diseases such as type 2 diabetes has been explored very recently, it remains to be seen what therapeutic efficacy of Lrig1 mAb stimulating Treg cell functions would show to the patient with type 2 diabetes. Here, LRIG1 is linked to metabolic disease.